DraftKings

Thesis, Rating & The Pair Call

DraftKings is the #2 US online sportsbook and iGaming operator — the other half of the FanDuel/DKNG duopoly that controls ~73% of US OSB GGR — and the cleanest listed pure-play on US betting. The story right now is a study in narrative framing against the same prediction-market backdrop that halved Flutter: where Flutter de-rated on the threat, DKNG has rallied ~10% in the past month on the same theme, because CEO Jason Robins has reframed prediction markets as “a massive, incremental opportunity” — a $5bn TAM DKNG attacks with up to $300m of EBITDA investment and a planned proprietary exchange. Underneath the framing, Q1 2026 was genuinely mixed: revenue +17% to $1.65bn and adjusted EBITDA +64% to $168m, but Monthly Unique Payers fell ~4% and EPS missed by ~44% on Predictions spend. FY26 guidance ($6.5–6.9bn revenue, $700–900m adjusted EBITDA) was held but landed below the Street.

HOLD, PT $30 (+19%) — and within the duopoly we prefer Flutter. DKNG is a high-quality, now-profitable scale operator, but it is the more expensive way to own the US betting duopoly: ~16× FY26E EBITDA (and a ~27×+ forward P/E) versus Flutter’s ~10.5×, with the same prediction-market uncertainty cutting both ways and a softer Q1 engagement read (MUPs −4%). The bull case is real — if the Predictions exchange delivers, the multiple resets upward and the stock can approach the high-$40s — but we are not paying a premium multiple for an unproven, EBITDA-dilutive opportunity when the larger, more diversified, FanDuel-owning leader trades cheaper. We rate DKNG HOLD with modest upside to $30 and flag the explicit pair preference: own the disruption through FLUT, not DKNG. Size fractionally; this is a high-variance pure-play.

Model & Competitive Position

DKNG is a vertically integrated, US-centric operator: sportsbook + iGaming (Golden Nugget Online) on a proprietary tech stack (SBTech heritage), now extending into prediction markets. Narrower than Flutter by geography and brand portfolio, but a focused bet on the highest-growth betting market on earth.

Five Forces, Condensed

• ▮Rivalry — stable duopoly, expensive to hold. FanDuel leads; DKNG #2; the two compound while the tail (CZR, BetMGM, Fanatics) fights for scraps. Promotional intensity caps margins.
• ▮New entrants — prediction markets, again. The same Kalshi/Polymarket threat — but DKNG is choosing to become an entrant on the federal rails rather than only defend.
• ▮Substitutes — event contracts as the substitute. DKNG’s thesis is that owning a proprietary exchange converts the substitute into its own product.
• ▮Supplier power — largely internalised. Proprietary tech post-SBTech; data from Sportradar/Genius like peers.
• ▮Buyer power — low, but engagement is the watch-item. The 4% MUP decline is the one crack in the demand story.

Prediction Markets & Litigation

The prediction-market debate dominates; a product-liability litigation thread sits underneath it.

The Prediction-Market Pivot — Offense, Not Defense

DKNG’s response to the CFTC-regulated event-contract threat is to build its own: a proprietary prediction-market exchange backed by up to $300m of EBITDA investment, positioned (per management) as a $5bn incremental opportunity rather than a defensive cost. The market has rewarded the framing — DKNG rallied while Flutter fell on identical industry news. Our read is more sober: the pivot is strategically sensible and DKNG’s entrenched user base is a real distribution advantage, but the opportunity is unproven, the spend is dilutive to near-term EBITDA (the Q1 EPS miss is the evidence), and the same structural risk — that federally-regulated contracts undercut state-taxed OSB economics — applies to DKNG’s core book regardless of whether its exchange succeeds. Offense and exposure are the same coin.

Contained Item — Addictive-Design Litigation

Status: allegations, unproven and contested; no findings. DKNG faces a product-liability suit (associated with the Public Health Advocacy Institute) alleging addictive product design, part of a broader wave of responsible-gambling litigation across the sector. We note it as a tail risk — potential for cost, distraction and regulatory read-through — not as a base-case impairment; the company is expected to defend. Sized as a risk-register item, not a thesis driver.

Q1 2026 & FY25 Milestone

Q1 2026 (quarter to 31 March) and the FY25 milestone frame a business that just turned profitable and is immediately reinvesting the profit.

The honest framing: DKNG has crossed into profitability (FY25 first GAAP profit; Q1 EBITDA +64%) exactly as it chooses to spend the incremental margin on Predictions. That is defensible capital allocation if the exchange works — but it means reported EBITDA understates core-book economics while overstating the certainty of the Predictions return. Both halves of that sentence matter.

Guidance & Our Numbers

Guidance and trajectory:

• ▮FY26E (guided): revenue $6.5–6.9bn (~13% growth at midpoint); adjusted EBITDA $700–900m (midpoint $800m), net of up to $300m Predictions investment. The wide EBITDA range is the Predictions uncertainty.
• ▮Core vs Predictions: ex-Predictions, underlying EBITDA would be materially higher — the guidance embeds a deliberate investment drag. Watch the FY27 step-up if Predictions investment moderates or starts contributing.
• ▮Longer arc: management/Street narratives point toward ~$8.9bn revenue and ~$900m+ earnings by ~2029 — requires ~14% revenue CAGR and the Predictions bet paying off; treat as a bull-path, not a base.
• ▮Watch items: MUP trend (engagement), Predictions exchange launch and economics, US iGaming legalisation, state tax trajectory, litigation developments.

Target, Multiple & Scenarios

At ~$25.30 the cap is ~$12.5bn; with modest net debt (convertibles partly offset by cash), EV is roughly $13bn — about 16× FY26E EBITDA ($800m midpoint), or a ~27×+ forward earnings multiple. That is a clear premium to Flutter’s ~10.5×, and the premium is the crux of the rating: DKNG grows the US faster and is the purer play, but it is not 50% better value, and the Predictions-dilution and MUP-softness arguments cut against paying up. Our $30 target applies ~18× to FY26E EBITDA (or normalises toward a high-teens multiple on FY27E as Predictions drag eases), implying ~19% upside — a HOLD with positive bias, set below the Street’s $34–55 range because we decline to capitalise an unproven exchange at full value. The pair conclusion stands: same theme, cheaper expression in FLUT.

Risk Register & Final Word

• ▮Prediction-market double-edge — both the bull catalyst and the core-book structural threat; the Predictions exchange may dilute without delivering.
• ▮Valuation premium — ~16× FY26E EBITDA / ~27× forward earnings leaves little margin for execution slips.
• ▮Engagement — the 4% MUP decline; acquisition discipline or demand saturation?
• ▮Litigation — addictive-design product-liability suits (PHAI-linked); cost/distraction/regulatory read-through (unproven; contested).
• ▮Regulatory / tax — state tax increases compress US margins; the ~$50m peer political spend signals the stakes.
• ▮Single-market concentration — far less geographic diversification than Flutter; a US-policy shock hits DKNG harder.

HOLD, $30 — prefer FLUT within the duopoly. DraftKings is a genuinely good business that just proved it can make money, now spending that proof on a prediction-market bet the market is choosing to applaud. We respect the strategy and the entrenched user base, but we will not pay a ~50% EBITDA-multiple premium to Flutter for the privilege of the same disruption risk and a softer engagement print. The cleaner risk/reward in US betting is the larger, cheaper, more diversified leader. Upgrade DKNG on: a successful Predictions-exchange launch with real cross-sell economics, or MUP re-acceleration. Downgrade on: continued engagement erosion or evidence the Predictions spend is a permanent drag. Kelly: small, and FLUT-weighted within the pair.

SOURCES & FLAGS. Q1’26 (revenue $1.65bn +16.8%; Sportsbook ~$1.09bn +24%; adj EBITDA $168m +64%; GAAP NI $21.1m; EPS $0.20 vs ~$0.22–0.36 cons; MUPs 4.2m −4%; FY26 guidance rev $6.5–6.9bn / adj EBITDA $700–900m; up-to-$300m Predictions investment; ~$50m peer political spend) from DKNG Q1 results coverage (8-K / Simply Wall St / 24-7 Wall St / Yahoo, May 2026); FY25 first GAAP profit on $6.05bn revenue +27% (8-K, 12 Feb 2026). Price ~$25.30 (2 Jun), 52-wk $20.46–$48.78, down ~27% YoY; cap ~$12.5bn on ~490m shares APPROXIMATE — verify share count and convertible debt vs 10-Q. Consensus targets $34.86 (28 Buy/7 Hold) to $54.68 avg (33 analysts). Addictive-design litigation (PHAI-linked): allegations only, unproven, contested. FY27E normalisation and PT multiple are OUR ESTIMATES. US OSB share ~36% per Mar 2026 trackers. USD throughout.

DISCLAIMER. Informational commentary only; not investment advice, an offer, or a solicitation. Prediction-market and litigation matters are evolving; no outcome is assured.